Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

7,997 public trials 1,823 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

Environment and Lung Cancer

NCT05119244

Conditions
Cannabis Use, Chemically-Induced Disorders, Lung Diseases, +9 more
Locations
  • Centre Chirurgical Marie Lannelongue Le Plessis-Robinson, France
  • Hopital Paris Saint Joseph Paris, France
  • Institut Gustave Roussy Villejuif, France
View Trial Details
Recruiting

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

NCT06800339

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake- Kaufman Cancer Center Bel Air, Maryland, United States
  • Baltimore Washington Medical Center- Tate Cancer Center Glen Burnie, Maryland, United States
View Trial Details
Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT06350097

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Fountain Valley, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 166 locations
View Trial Details
Recruiting

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT07111520

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
  • Moffit Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 68 locations
View Trial Details
Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

NCT06616584

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 386 locations
View Trial Details
Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

NCT06343402

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • O'Neal Comprehensive Cancer Center at UAB Birmingham, Alabama, United States
  • University of California - San Diego Moores Cancer Center La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • UCLA Health - Santa Monica Cancer Care Santa Monica, California, United States
View all 35 locations
View Trial Details

Related conditions